Jessica Yingling, Ph.D.
Jessica Yingling, Ph.D. is the president of Little Dog Communications. Little Dog clients represent the full range of biotechnology companies and include those developing novel therapeutics, diagnostics, and devices that can make a meaningful difference in the lives of patients. Prior to Little Dog, Jessica was director of corporate communications at Fate Therapeutics. Jessica earned her Ph.D. in biomedical sciences from UC San Diego and a B.S. with honors in biochemistry from the University of Arizona.
Articles by Jessica:
-
Biotech Briefing: Will More Female Leaders Drive Innovation?
Plus: UC San Diego reports its first results from the largest microbiome study, and Illumina acquires Edico Genomics
Read More » -
Biotech Briefing: A Hepatitis C Drug Could Treat Zika Infections
Plus: 10,000 Maniacs hold concert for Parkinson’s disease research, and the influence of San Diego’s first biotech
Read More » -
Biotech Briefing: Salk Institute Scientists Develop Cell Therapy for Hemophilia
Plus: Scripps Translational Science Institute receives $34 million NIH award
Read More » -
Biotech Briefing: San Diego Is Facing an Alzheimer’s Epidemic and We’re Not Prepared
Plus: Synthetic Genomics featured in Fast Company‘s World Changing Ideas
Read More » -
Biotech Briefing: Second Annual March for Science Is This Saturday
Plus: UC San Diego microbiologist’s research helps make the best cheese, and San Diego startups raise more than 500 million venture dollars
Read More » -
Biotech Briefing: UCSD Researchers Find Non-Coding DNA Mutations Can Cause Cancer
Plus: Scripps research grad school recognized as Top 10 for chemistry and biology, and Wisconsin startup moves to San Diego
Read More » -
Biotech Briefing: TSRI Finds Rare Genetic Mutation Protects Against Malaria
Plus: Dexcom receives FDA green light for the first interoperable CGM, and the top biotech events this month
Read More » -
Biotech Briefing: Encinitas Biotech Raises $19 Million for Autoimmune Therapies
Plus: A 50-year timeline of UC San Diego’s School of Medicine, and the 2018 winners of the Greater San Diego Science and Engineering Fair
Read More » -
Biotech Briefing: ExxonMobil and Synthetic Genomics Move to Grow Algae Biofuel Outside
Plus: Are unicorns overrated, and what is the alternative?
Read More » -
Biotech Briefing: Why Can’t the Drug Industry Solve Its Gender Diversity Problem?
Plus: Vividion Therapeutics and Celgene collaborate on intractable drug targets
Read More » -
Biotech Briefing: UC San Diego Researchers Use AI to Diagnose Eye Diseases
Plus: TSRI scientists shed light on genome’s dark matter, and Fate Therapeutics wins CIRM grant
Read More » -
Biotech Briefing: FDA Approves First Objective Test for Traumatic Brain Injury
Plus: MediciNova raises $40 million to advance multiple sclerosis drug, and more San Diego biotech news
Read More » -
Biotech Briefing: Rady Children’s Hospital Sets World Record for Fastest Genome Sequencing
Plus: TSRI receives $10 million grant to find new therapies for alcohol abuse
Read More » -
Biotech Briefing: Sanford Burnham Prebys Says Off-the-Shelf Drugs Could Manage Zika
Plus: Organovo founder pays it forward, and MedCity News questions investing in oncology
Read More » -
Biotech Briefing: Synthetic Genomics Speeds up Production of Flu Vaccines
Plus: TSRI receives donation for graduate program fellowships, and UC San Diego School of Medicine turns 50
Read More » -
Biotech Briefing: UCSD Researchers Activate Cancer-Killing Cells with Ultrasound
Plus: Salk names interim president and Shanghai Pharmaceuticals plans to open research center in San Diego
Read More » -
Biotech Briefing: San Diego Startups Raised $1.93 Billion in Venture Capital in 2017
Plus: TSRI scientists find therapeutic target for Marburg virus
Read More » -
Biotech Briefing: Local Researchers Map Brain Disorders for Better Drug Development
Plus: Celgene buys Impact cancer drug, and Expansion Therapeutics plans to develop RNA-targeting drugs
Read More » -
Biotech Briefing: Gates Foundation Supports Sirenas’ Marine Drug Discovery
Plus: San Diego EDC’s top 10 stories and what to do with a genetic testing kit
Read More » -
Biotech Briefing: Ionis Licenses Huntington’s Disease Drug to Roche
Plus: Fate Therapeutics makes five announcements and Michael Pellini joins Section 32 Venture Fund
Read More » -
Biotech Briefing: 3 San Diego Researchers Win Breakthrough Prizes
Plus: Connect celebrates 30 years of Most Innovative New Product Awards and Synthorx had a big week
Read More »
